Skip to main content

Table 2 Univariate Cox regression models to predict disease-free survival according to residual cancer in on-treatment biopsies during neoadjuvant chemotherapy

From: On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer

Subtype

Covariate

Hazard ratio (95% CI)

P

HR−/HER2−

tu− vs. tu+

0.402 (0.163–0.987)

0.047

HR+/HER2−

tu− vs. tu+

1.039 (0.428–2.525)

0.933

HER2+

tu− vs. tu+

1.77 (0.577–5.43)

0.318